Skip to main content

Table 2 Comparison of study participants who retained in MMT and those who dropped out of MMT at 6-month follow-up

From: Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study

 

Retained in MMT at 6-month follow-up (n = 285)

Dropped out of MMT at 6-month follow-up (n = 314)

χ 2/t

p

 

n(%)

M( SD)

n(%)

M( SD)

  

Gender

    

0.49

0.48

 Male

245(86.0)

 

276(87.9)

   

 Female

40(14.0)

 

3(12.1)

   

Age

 

41.02(9.32)

 

40.16(9.09)

1.15

0.25

Marital Status

(n = 284)

 

(n = 263)

 

4.12

0.25

 Married

85(29.9)

 

61(23.2)

   

 Single

141(49.7)

 

149(56.6)

   

 Divorced/Widowed/Other

58(20.4)

 

53(20.2)

   

Education (years)

 

9.22(2.26)

(n = 309)

9.1(2.17)

0.29

0.77

Age at first-time heroin intake

(n = 283)

27.74(7.36)

(n = 218)

26.65(7.34)

1.65

0.10

HIV status

(n = 275)

 

(n = 301)

 

0.01

0.93

 Positive

34(12.4)

 

38(12.6)

   

 Negative

241(87.6)

 

263(87.4)

   

HCV Status

(n = 264)

 

(n = 287)

 

1.11

0.58

 Positive

248(93.9)

 

264(92.0)

   

 Negative

16(6.1)

 

23(8.0)

   

Morphine status at baseline

(n = 247)

 

(n = 266)

 

2.55

0.28

 Positive

69(27.9)

 

90(33.8)

   

 Negative

178(72.1)

 

176(66.2)

   

Methadone dose at treatment intake (mg/day) (SD)

(n = 283)

39.19 (20.86)

(n = 313)

38.58 (19.90)

0.37

0.72

Days enrolled in MMT before this study (SD)

(n = 216)

194.44 (157.86)

(n = 282)

175.77 (145.10)

1.37

0.17

Employed

(n = 279)

 

(n = 292)

 

0.44

0.51

 Yes

187 (67.0)

 

188(64.4)

   

 No

92(33.0)

 

104(35.6)

   
  1. Note. Variables with missing values were deleted from the analyses. Chi-square and t-test analyses were performed on categorical and continuous variables respectively to determine if there were differences between dropouts and those who stayed.